Kitazato

Kitazato Rule of 40

The Rule of 40 of Kitazato (368A.T) as of Nov 17, 2026 is 58.33 %. In the previous year, Rule of 40 was 66.48 % — a change of -12.27% (lower).

Rule of 40

58.33 %

YoY

-12.27%

Last updated:

Rule of 40 of Kitazato is 2025 58.33 % . Rule of 40 of Kitazato was 2024 66.48 % . It decreases by -12.27% lower compared to the previous year.

The Kitazato Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2024
66.48 JPY
Jan 1, 2025
58.33 JPY
The Kitazato Rule of 40 history
YEARRule of 40YoY
58.33 %-12.27%
66.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Rule of 40 of Kitazato is 58.33 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Kitazato since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Kitazato

All Key Metrics — Kitazato